<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD07950000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q96FW1</UniProt_ID>
  <Seq_Length>271</Seq_Length>
  <Molecule_Weight>31284</Molecule_Weight>
  <KEGG_ID>hsa:55611</KEGG_ID>
  <Orthology_ID>K09602</Orthology_ID>
  <EBI_ID>EBI-1058491</EBI_ID>
  <Function_Summary>Hydrolase that can remove conjugated ubiquitin from proteins and plays an important regulatory role at the level of protein turnover by preventing degradation. Regulator of T-cell anergy, a phenomenon that occurs when T-cells are rendered unresponsive to antigen rechallenge and no longer respond to their cognate antigen. Acts via its interaction with RNF128/GRAIL, a crucial inductor of CD4 T-cell anergy. Isoform 1 destabilizes RNF128, leading to prevent anergy. In contrast, isoform 2 stabilizes RNF128 and promotes anergy. Surprisingly, it regulates RNF128-mediated ubiquitination, but does not deubiquitinate polyubiquitinated RNF128. Deubiquitinates estrogen receptor alpha (ESR1). Mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains, but not 'Lys-63'-linked polyubiquitin chains. Not able to cleave di-ubiquitin. Also capable of removing NEDD8 from NEDD8 conjugates, but with a nuch lower preference compared to 'Lys-48'-linked ubiquitin.</Function_Summary>
  <Catalytic_Mechanism>Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).</Catalytic_Mechanism>
  <Pfam_ID>PF10275:Peptidase_C65</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Deubiquitinating enzyme OTUB1</Alias>
      <Alias>hOTU1</Alias>
      <Alias>Ubiquitin-specific-processing protease OTUB1</Alias>
      <Alias>OTU domain-containing ubiquitin aldehyde-binding protein 1</Alias>
      <Alias>Otubain-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently and non-covalently with ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.</Detail>
      <Keyword>Ubiquitin binding</Keyword>
      <Ontology_ID>GO:0043130</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the removal of terminal peptide residues that are substituted, cyclized or linked by isopeptide bonds (peptide linkages other than those of alpha-carboxyl to alpha-amino groups).</Detail>
      <Keyword>Omega peptidase activity</Keyword>
      <Ontology_ID>GO:0008242</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various forms of polymeric ubiquitin sequences.</Detail>
      <Keyword>Ubiquitin-specific protease activity</Keyword>
      <Ontology_ID>GO:0004843</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of NEDD8, a small ubiquitin-related modifier, from previously neddylated substrates.</Detail>
      <Keyword>NEDD8-specific protease activity</Keyword>
      <Ontology_ID>GO:0019784</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in adaptive immunity. Vertebrates can develop a broad and almost infinite repertoire of antigen-specific receptors, which allows vertebrates to recognize almost any potential pathogen or toxin and to mount antigen-specific responses to it. Two types of adaptive immunity systems have evolved in vertebrates in order to generate immune receptor diversity. The jawed vertebrates strategy uses the V(D)JC recombination to achieve combinatorial diversity of immunoglobulin-based B cell receptors and T cell receptors. The jawless vertebrate strategy uses the somatic rearrangements of variable leucine-rich cassettes in the variable lymphocyte receptors (VLRs). The hallmarks of an adaptive immune system is the production of antigen-specific recognition receptor by somatic gene rearrangement. The long life of some antigen-primed cytotoxic lymphocytes and plasma cells provide protective memory to prevent reinvasion.</Detail>
      <Keyword>Adaptive immunity</Keyword>
      <Ontology_ID>KW-1064</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein.</Detail>
      <Keyword>Protein K48-linked deubiquitination</Keyword>
      <Ontology_ID>GO:0071108</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>16</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>188</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MAAEEPQQQKQEPLGSDSEGVNCLAYDEAIMAQQDRIQQEIAVQNPLVSERLELSVLYKEYAEDDNIYQQKIKDLHKKYSYIRKTRPDGNCFYRAFGFSHLEALLDDSKELQRFKAVSAKSKEDLVSQGFTEFTIEDFHNTFMDLIEQVEKQTSVADLLASFNDQSTSDYLVVYLRLLTSGYLQRESKFFEHFIEGGRTVKEFCQQEVEPMCKESDHIHIIALAQALSVSIQVEYMDRGEGGTTNPHIFPEGSEPKVYLLYRPGHYDILYK</Protein_Seq>
    <DNA_Seq>AGTTAGGTCATGAGGCTTTGGCCTTGACACCAAGGGATGCTGTCTCCTTGCCGGAAGCAGCTCACCAAAGCCGGCAGAGAACCCAGGTTCCGTGGGGCCACGATGTGGGGCTCCGCGGGCGCCCCGGCGCTGGCCGACTTCCTGTCTCCTGGGTCAGATGCTGCTCCGCACTGCAGCTATGGTCGCATGCAGTGCCTGCCGAAGCCCGCAGCAGGAATGCTGCCTTCGGTGATTTTAATTTCACTTTTCTACTTCTCTCAATAACAAAATCCGCGTTTCAAACTCCAGGGAAAAGAAAACGGAATTGGCTCCAGGAGGATCTGCAATCACCACCGGGAACTTTGGGAGGCTGGGAAGATGGAGCCAAACCAATGTGTGGGGTGGAGGTGCGGATCTGGGGCGGCCGGCCTCTCCTACAGGTCTCAGGTCCGCAGGCCTGGCGTGCCAGCACCTGCCACGGGACTGGAAGCCCATTCCTTGACAACGCCTAAGGGGATCCCGTTGCTAGGGCTGTTGCCAAGGCGGGGCAACGAGGAGGGGCTCGCTTCCGGGAGGACGGCAATTGGCAACCCGGAAGCGGTCGGTAGTGCGGCGCTGTTTAAAGATGGCGGCGGAGGAACCTCAGCAGCAGAAGCAGGAGCCGCTGGGCAGCGACTCCGAAGGTGTTAACTGTCTGGCCTATGATGAAGCCATCATGGCTCAGCAGGACCGAATTCAGCAAGAGATTGCTGTGCAGAACCCTCTGGTGTCAGAGCGGCTGGAGCTCTCGGTCCTATACAAGGAGTATGCTGAAGATGACAACATCTATCAACAGAAGATCAAGGACCTCCACAAAAAGTACTCGTACATCCGCAAGACCAGGCCTGACGGCAACTGTTTCTATCGGGCTTTCGGATTCTCCCACTTGGAGGCACTGCTGGATGACAGCAAGGAGTTGCAGCGGTTCAAGGCTGTGTCTGCCAAGAGCAAGGAAGACCTGGTGTCCCAGGGCTTCACTGAATTCACAATTGAGGATTTCCACAACACGTTCATGGACCTGATTGAGCAGGTGGAGAAGCAGACCTCTGTCGCCGACCTGCTGGCCTCCTTCAATGACCAGAGCACCTCCGACTACCTTGTGGTCTACCTGCGGCTGCTCACCTCGGGCTACCTGCAGCGCGAGAGCAAGTTCTTCGAGCACTTCATCGAGGGTGGACGGACTGTCAAGGAGTTCTGCCAGCAGGAGGTGGAGCCCATGTGCAAGGAGAGCGACCACATCCACATCATTGCGCTGGCCCAGGCCCTCAGCGTGTCCATCCAGGTGGAGTACATGGACCGCGGCGAGGGCGGCACCACCAATCCGCACATCTTCCCTGAGGGCTCCGAGCCCAAGGTCTACCTTCTCTACCGGCCTGGACACTACGATATCCTCTACAAATAGGGCTGGCTCCAGCCCGCTGCTGCCCTGCTGCCCCCCTCTGCCAGGCGCTAGACATGTACAGAGGTTTTTCTGTGGTTGTAAATGGTCCTATTTCACCCCCTTCTTCCTGTCACATGACCCCCCCCCATGTTTTATTAAAGGGGGTGCTGGTGGTGAGCCGTGTGTGCGTGTCCCTGCTCTGCTGCCCGCCTGGCTGCTCTGTCTGCTGCCCCCTCCCCCCAGGTGGGTCCCCCTGCTTTTCACCTATCTACTCCTGAGCTTCCCCAACAGGAGCAGGTTTGAGGGGCCAGGCCTCTTGGAGGCCCCTCCTGCTTCGTTGGGTTCTGCTTCCTTCCCTTCTTAGCTGGCTCAGGGGCTTCTATGGGATCCTGGAAGTTCCTTAGGGACTTGCCCAGGGTCCCAGGGCCACCCACACTTCATCTGCTCCCTCATAGGCCCCACCTCCACGTCCCGGCTGGGCCCCAGACCCCAGCTTCCTGCCCTCCACCGGGAGTCTGCATGGTTGGGAGTCCTGGGTGGAGGGGCCTTTGTGAGGCTGGACCCGGCTCAGGGCAGGTGGAGGAGCTGGGCCTCCCACAGGGTGCCCGGGCAGTGCCATCCTGGTGGGGGAGGGCAGCCTTCAAACGTGTGGGGTCTACAGTCCTCAGGTCTAGGCAGGGCTGCCGGTTCTCCACCTCCCCATCCGCCCCAGGCCCCCTGCCTGTGCCTGCCTTGCACCCCCTCTGCTTGGGCCACGGTGTCTCTGCATTGCCTGCCTTTTTGCCTTCACCTCTTTTCTTCCCCGCCCCCTGCACATTCGGGGTCTCAGCCCCCAGGCTGTGAGCTCCTTGGGGGCAGGCCCTCAATAAATGTGAACTGCTGCTGCCGCCTCTGCAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Lymphoid tissues</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Peripheral blood mononuclear cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>OTUB1</Gene_Name>
    <Gene_Alias>OTB1; OTU1</Gene_Alias>
    <Gene_ID>55611</Gene_ID>
    <Genbank_ACCN>NM_017670</Genbank_ACCN>
    <Protein_ACCN>NP_060140</Protein_ACCN>
    <HGNC_ID>23077</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/55611</Gene_URL>
    <UCSC_ID>uc001nyg.1</UCSC_ID>
    <EMBL_ID>ENSG00000167770</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P62837</Uniprot_ID>
      <Gene_Name>UBE2D2</Gene_Name>
      <EBI_ID>EBI-347677</EBI_ID>
      <PPI_EBI_URL>EBI-1058491,EBI-347677</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of human OTUB1/UbcH5b~Ub/Ub</PDB_Title>
      <PDB_ID>4DDG</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DDG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>OTUB1 Co-opts Lys48-Linked Ubiquitin Recognition to Suppress E2 Enzyme Function.</PubMed_Title>
      <Author>Juang, Y.C., et al.</Author>
      <Journal>Mol.Cell(2012)45:384-397</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22325355?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human OTUB1/UbcH5b~Ub/Ub</PDB_Title>
      <PDB_ID>4DDI</PDB_ID>
      <Resolution>3.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DDI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>OTUB1 Co-opts Lys48-Linked Ubiquitin Recognition to Suppress E2 Enzyme Function.</PubMed_Title>
      <Author>Juang, Y.C., et al.</Author>
      <Journal>Mol.Cell(2012)45:384-397</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22325355?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human Otubain 1</PDB_Title>
      <PDB_ID>2ZFY</PDB_ID>
      <Resolution>1.69</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZFY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis and specificity of human otubain 1-mediated deubiquitination.</PubMed_Title>
      <Author>Edelmann, M.J., et al.</Author>
      <Journal>Biochem.J.(2009)418:379-390</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18954305?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The structure of h/ceOTUB1-ubiquitin aldehyde-UBC13~Ub</PDB_Title>
      <PDB_ID>4DHZ</PDB_ID>
      <Resolution>3.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DHZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The mechanism of OTUB1-mediated inhibition of ubiquitination.</PubMed_Title>
      <Author>Wiener, R., et al.</Author>
      <Journal>Nature(2012)483:618-622</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22367539?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Protein-induced</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.19.12</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/19/12.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>